EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Utilization of adjunctive anti-seizure medications to facilitate chronic benzodiazepine discontinuation

Michael R Dueno iD, Gavin T Howington iD, Melody Ryan iD

Mental Health Clinician · 2026-06 · 16 (3) · 141-149

DOI: 10.9740/mhc.2026.06.141 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Mental Health Clinician, 2026-06. Verfasst von Michael R Dueno und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Kentucky College of Pharmacy, Lexington, Kentucky. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

When discontinuing benzodiazepines, treating withdrawal symptoms can be challenging. Some anti-seizure medications (ASM) may mitigate withdrawal symptoms. This article reviews the literature regarding adjunctive ASM use during benzodiazepine tapering and discontinuation.

Methods

A PubMed search focusing on the use of ASMs as adjunctive agents to mitigate benzodiazepine withdrawal symptoms was conducted. Key search teams identified relevant articles, and the references of included articles were evaluated to identify potential additional publications for inclusion. In total, 21 articles met the inclusion criteria, and 44 articles were excluded for various reasons.

Results

Several clinical trials, observational studies, case reports, and case series were identified. Carbamazepine was more effective than placebo at 3 months (74% benzodiazepine free vs 52% for placebo). Oxcarbazepine enabled successful rapid detoxification with minimal withdrawal symptoms in a small, noncontrolled study. Valproate, pregabalin, and gabapentin showed improvements in benzodiazepine-free rates, but the results were inconsistent.

Discussion

Evidence for ASM in benzodiazepine withdrawal is limited, emphasizing the need for provider discretion. Additional larger clinical trials are warranted to identify optimal agents to mitigate withdrawal symptoms and enhance successful benzodiazepine cessation.

Schlagwörter

Stichwörter der Autor:innen

adjunctive therapyanticonvulsantsbenzodiazepine discontinuationbenzodiazepine withdrawalcarbamazepinegabapentinoids

Autor:innen und Institutionen

  • University of Kentucky College of Pharmacy, Lexington, Kentucky.
  • (Corresponding author) Associate Professor & Emergency Medicine Pharmacist, University of Kentucky College of Pharmacy, and University of Kentucky HealthCare, Lexington, Kentucky, gavin.howington@uky.edu.
  • Professor, University of Kentucky College of Pharmacy, Lexington, Kentucky.

ORCID-Profile: Michael R Dueno, Gavin T Howington, Melody Ryan

Zitieren

APA

Dueno, M. R., Howington, G. T., & Ryan, M. (2026). Utilization of adjunctive anti-seizure medications to facilitate chronic benzodiazepine discontinuation. Mental Health Clinician, 16(3), 141-149. https://doi.org/10.9740/mhc.2026.06.141

Vancouver

Dueno MR, Howington GT, Ryan M. Utilization of adjunctive anti-seizure medications to facilitate chronic benzodiazepine discontinuation. Mental Health Clinician. 2026;16(3):141-149. doi:10.9740/mhc.2026.06.141

BibTeX
@article{Dueno2026,
  author = {Dueno, Michael R and Howington, Gavin T and Ryan, Melody},
  title = {Utilization of adjunctive anti-seizure medications to facilitate chronic benzodiazepine discontinuation},
  journal = {Mental Health Clinician},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {141--149},
  doi = {10.9740/mhc.2026.06.141}
}
Kostenlos starten →